Remove 2030 Remove Competition Remove Sales
article thumbnail

Bayer sells testosterone drug rights to Grünenthal for €500m

pharmaphorum

Grünenthal is paying up to €500 million ($501 million) for rights to Nebido (testosterone undecanoate), which is sold in around 80 countries worldwide for testosterone deficiency and made sales of €117 million last year.

article thumbnail

$2 billion mRNA-based oncology therapy market anticipated by 2029

European Pharmaceutical Review

BioNTech is anticipated to lead the market with a predicted $885 million in sales, and a 44.6 billion by 2030 BioNTech Development of mRNA-based oncology therapies for German biotech BioNTech is progressing. OTX-2002 from Omega Therapeutics is an mRNA therapy anticipated to generate $658 million in global sales, representing 33.2

Marketing 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2022 Sales Hiring Forecast

Sales Talent

At the beginning of each year, we compile our sales hiring forecast by looking at the overall hiring forecasts for the year made by Manpower, Glassdoor, Indeed, Monster, and the Bureau of Labor & Statistics (BLS). 2021 Sales Hiring in Review. 2021 Sales Hiring in Review. 2022 Sales Forecast for Hiring.

Sales 52
article thumbnail

Is Medical Sales Still A Lucrative Job?

Contrarian Sales Techniques

Medical sales can be a lucrative job , but it depends on a number of factors , including the specific products or services being sold, the company or industry sector, and the individual's sales performance. Additionally, the medical sales industry is expected to grow in the coming years.

article thumbnail

Eli Lilly achieving significant gains in obesity results

Pharmaceutical Technology

Mounjaro’s approval for obesity, particularly in the US and EU markets, means the drug is entering a significantly large market where it will have direct competition from Novo Nordisk’s Wegovy (semaglutide), which is currently the leading glucagon-like peptide-1 (GLP-1) therapy approved for obesity by both the FDA and EMA.

Leads 98
article thumbnail

Sun Pharma agrees deal to buy alopecia player Concert

pharmaphorum

per share deal includes $8 per share upfront, worth around $576 million, with the remainder in the form of a contingent value right (CVR) that will be paid to Concert shareholders if deuroxilitinib meets certain sales targets within a set time limit. The $11.50 The report predicts that the alopecia areata market will grow to as much as $2.5

Pharma 98
article thumbnail

The Solar Sales Funnel: From Awareness To Action

Spotio

You need to optimize your company’s solar sales funnel. Of course, wanting to improve your solar sales process and actually doing it are different things. Understanding Solar Sales Before we discuss the various stages of the solar sales funnel, let’s zoom out and analyze the industry as a whole.

Sales 52